Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Change in Accured Expenses (2020 - 2026)

Opus Genetics has reported Change in Accured Expenses over the past 12 years, most recently at $432000.0 for Q1 2026.

  • Quarterly Change in Accured Expenses rose 58.82% to $432000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$3.3 million through Mar 2026, down 179.08% year-over-year, with the annual reading at -$3.5 million for FY2025, 161.59% down from the prior year.
  • Change in Accured Expenses was $432000.0 for Q1 2026 at Opus Genetics, up from -$873000.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $2.4 million in Q4 2024 and troughed at -$1.9 million in Q2 2025.
  • The 5-year median for Change in Accured Expenses is $1000.0 (2022), against an average of $157882.4.
  • Year-over-year, Change in Accured Expenses skyrocketed 149700.0% in 2023 and then crashed 1109.94% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $461000.0 in 2022, then tumbled by 125.16% to -$116000.0 in 2023, then soared by 2129.31% to $2.4 million in 2024, then crashed by 137.09% to -$873000.0 in 2025, then soared by 149.48% to $432000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRD's Change in Accured Expenses are $432000.0 (Q1 2026), -$873000.0 (Q4 2025), and -$946000.0 (Q3 2025).